ChristianityTodayLibrary.com
Member Login  |  E-mail:  Password    Not a member?  Join now!
home
 Search:  browse by topicbrowse by publicationhelp

Seminary &
Grad School Guide
Search by Name
 

or use:
Advanced Search
to search by major, region, cost, affiliation, enrollment, more!

Search by
Location & Setting
Programs & Degrees
Enrollment
Affiliation
Athletics
Costs, Scholarships & Grants
List All Schools


Member Services
My Account
Contact Us
Christianity TodayAugust (Web-only) 2005

FREE ARTICLE PREVIEW

 ARTICLE TOOLS


Frist's Folly
Killing human embryos for research is not pro-life.



Being pro-life used to mean, at a minimum, that you believe life begins at conception and that this life is worthy of protection at all stages of development. Sen. Bill Frist would like to "modify" that just a bit.

First, a little background. On August 9, 2001, you'll recall, President Bush announced a compromise. He would allow federal funding of embryonic stem-cell (ESC) research. But he restricted this government support to the 78 or so ESC lines that had already been created as of that date, "where the life and death decision has already been made." Thus, Bush said that the government should not encourage, nor should taxpayers pay for, research that involves the destruction of human life. At that time, Frist, who is a heart- and lung-transplant physician, announced he would support the policy.

Scientists value stem cells because of their purported ability to grow into other kinds of tissue and inaugurate a new era of regenerative medicine. "In all forms of stem-cell research," Dr. Frist said Friday, "I see today … great promise to heal. Whether it's diabetes, Parkinson's disease, Lou Gehrig's disease, or spinal cord injuries, stem cells offer hope for treatment that other lines of research cannot offer."

Currently, there are two kinds of stem cells. The first is so-called adult stem cells, derived from umbilical cord blood and other areas of the human body. So far adult stem cells have provided treatments for at least 65 conditions in humans.

The second kind comes from human embryos. Scientists value these ESCs because they are pluripotent, having the ability to become any kind of human tissue. ESCs also have the ability to reproduce themselves indefinitely. So far, however, after 24 years of research using both mouse ...



Are you a CTLibrary member or a Christianity Today subscriber with archives privileges?
To read the rest of this article, log in here:
E-mail  Password  

If you're a Christianity Today print subscriber...
...but have not yet registered for online access to CTLibrary.com, you can receive a full-year's access for just $29.95!

Register Here
 If you're NOT a Christianity Today print subscriber...
You're entitled to a special, introductory offer for new subscribers only! Subscribe now and receive a one-year Christianity Today print magazine subscription and one-year access to all Christianity Today archives for just $39.95!

Subscribe now!


Subscribe!

Subscribe to Christianity Today
Risk-free trial issue

Give a gift subscription


Shopping
ChristianBook.com
  Books|Music|Videos|Gifts

Bible Studies
Christian History
Leadership Training
Small Group Resources

Featured Items




















Subscribe to CTDirect
Get CT headlines in your mailbox every day!




ChristianityToday.com
HomeCT MagChurch/MinistryBible/LifeCommunitiesEntertainmentSchools/JobsShoppingFree!Help
Magazines:
Books & Culture
Christian History & Biography
Christianity Today
Church Law Today
Church Treasurer Alert
Ignite Your Faith
Leadership Journal

Men of Integrity
MOMsense
Today's Christian
Today's Christian Woman
Your Church
ChristianityTodayLibrary.com
Resources:
BuildingChurchLeaders.com
ChristianBibleStudies.com
Christian College Guide
Christian History Back Issues
Christian Music Today
Christianity Today Movies

Church Products & Services
Church Safety
ChurchSiteCreator.com
PreachingToday.com
PreachingTodaySermons.com
Seminary/Grad School Guide


Christianity Today International
www.ChristianityToday.com
Copyright © 1994–2008 Christianity Today International
Privacy Policy | Contact Us | Advertise with Us